Wednesday - May 14, 2025
DES MOINES, Iowa, Oct. 2, 2024 /PRNewswire/ -- Ambetter Health, a product offered by a Centene Corporation (NYSE: CNC) company, which provides insurance to under-insured and uninsured populations through the federal Health Insurance Marketplace®, will now offer Iowans a variety of affordable health insurance plans to residents in 33 counties in Iowa in 2025. Open enrollment for the Health Insurance Marketplace for Iowa runs from Nov. 1, 2024, through Jan. 15, 2025. Enroll by Dec. 15 for coverage starting Jan. 1, 2025.
"With Ambetter Health, we've designed a variety of coverage options to help individuals access viable health solutions designed to meet their unique needs," said Mitch Wasden, Plan President & CEO of Iowa Total Care. "Our commitment is not just to provide high-quality insurance, but to build a healthier Iowa for all, where every member feels valued, supported and equipped to thrive."
Ambetter Health offers its members access to quality care, convenient services and valuable rewards. The 2025 benefits and offerings include:
Below is a full list of the counties in which Ambetter Health will be offered in 2025:
Iowa residents interested in learning more about Ambetter Health or enrolling in a health plan during the open enrollment period may visit ambetterhealth.com/en/ia.
About Ambetter Health
Ambetter Health serves under-insured and uninsured populations through the federal Health Insurance Marketplace. Ambetter Health is underwritten by Iowa Total Care, Inc., which is a Qualified Health Plan issuer in Iowa. For more information, please visit ambetterhealth.com/en/ia/. This is a solicitation for insurance. For information on your right to receive an Ambetter Health plan free of discrimination, or your right to receive language, auditory and/or visual assistance services, please visit ambetterhealth.com/en/ and scroll to the bottom of the page.
Last Trade: | US$58.97 |
Daily Change: | -3.90 -6.20 |
Daily Volume: | 8,553,801 |
Market Cap: | US$29.770B |
April 25, 2025 February 24, 2025 February 04, 2025 |
Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MORECompass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MOREEnd of content
No more pages to load